Liability insurance of drug clinical trial
Of the 29 new drug trials, 44.8% (13/29) of the sponsors purchased commercial insurance for subjects during the trial. Interestingly, these are trials evaluating BE and human pharmacokinetics. Such insurance is usually for compensate for injury or death related to the investigational drugs. In general, the cumulative liability limit is generally between RMB 300,000 and RMB 500,000 per person. Since ChiCTR platform does not require filling in relevant insurance information , it is unclear whether the insurance is purchased or not on the post-marketing studies.